ロード中...
Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome—What is the evidence?
Aspirin and heparin are widely used to reduce the risk of recurrent pregnancy loss in women with antiphospholipid syndrome. This practice is based on only a few intervention studies, and uncertainty regarding benefits and risk remains. In this case‐based review, we summarize the available evidence a...
保存先:
| 出版年: | J Thromb Haemost |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8252114/ https://ncbi.nlm.nih.gov/pubmed/33687789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15290 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|